KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Shares Issued (2016 - 2025)

Cvs Health (CVS) has disclosed Shares Issued for 17 consecutive years, with $86.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued rose 352.63% year-over-year to $86.0 million, compared with a TTM value of $394.0 million through Dec 2025, up 9.14%, and an annual FY2025 reading of $394.0 million, up 9.14% over the prior year.
  • Shares Issued was $86.0 million for Q4 2025 at Cvs Health, down from $117.0 million in the prior quarter.
  • Across five years, Shares Issued topped out at $297.0 million in Q1 2022 and bottomed at $19.0 million in Q4 2024.
  • Average Shares Issued over 5 years is $106.6 million, with a median of $109.5 million recorded in 2021.
  • The sharpest move saw Shares Issued skyrocketed 883.33% in 2021, then crashed 67.68% in 2023.
  • Year by year, Shares Issued stood at $109.0 million in 2021, then crashed by 62.39% to $41.0 million in 2022, then dropped by 14.63% to $35.0 million in 2023, then tumbled by 45.71% to $19.0 million in 2024, then surged by 352.63% to $86.0 million in 2025.
  • Business Quant data shows Shares Issued for CVS at $86.0 million in Q4 2025, $117.0 million in Q3 2025, and $47.0 million in Q2 2025.